prmarks logo

Synaffix and Mitsubishi Tanabe Pharma Sign License Agreement for ADC Technology

News provide by
702Padmin
Jan 09, 2025, 5:00 AM PST

Share this article

License agreement centered around development of a single ADC program Usage of Synaffix GlycoConnect®, HydraSpace® and toxSYN® ADC technologies to enhance efficacy, tolerability and target engagement AMSTERDAM, Jan. 9, 2025 /PRNewswire/ — Synaffix B.V. (“Synaffix”), a Lonza company (SWX:…